We’re making our innovative tinnitus services accessible to even more people across the UK by exploring collaborations within the NHS. This milestone represents a significant step forward in addressing the challenges of tinnitus with evidence-based, digital-first care. For more information, please see below: https://lnkd.in/ec7z-68P
关于我们
Oto’s app will teach you to tune out tinnitus in 90 days. With a clinically proven program that mimics face-to-face treatment, Oto has supported over 50,000 people to get their life back from tinnitus.
- 网站
-
https://www.joinoto.com/
Oto的外部链接
- 所属行业
- 健康与健身服务
- 规模
- 2-10 人
- 总部
- London
- 类型
- 私人持股
- 领域
- digital health、audiology、health tech、otolaryngology 和tinnitus
地点
-
主要
GB,London
Oto员工
动态
-
Oto is now available in France. Until now, people with tinnitus have struggled to access evidence-based treatment, despite cognitive behavioural therapy (CBT) being recommended in the latest Haute Autorité de Santé guidelines. Now, with Oto, the 6 million people in France living with tinnitus can instantly access CBT. Available through prescription by a doctor via AppThera. ----------------------------------- Oto est désormais disponible en France. Jusqu'à présent, les personnes souffrant d'acouphènes avaient du mal à accéder à un traitement fondé sur des preuves, bien que la thérapie cognitivo-comportementale (TCC) soit recommandée dans les dernières directives de la?Haute Autorité de Santé. Désormais, avec Oto, les 6 millions de personnes vivant avec des acouphènes en France peuvent accéder instantanément à la TCC. Disponible sur prescription médicale via?AppThera.
-
-
?? Want to offer better outcomes for your tinnitus patients? Join me at the InFocus: Rethinking Tinnitus Symposium, November 19-21, 2024. We’ll explore advanced approaches and new insights for managing tinnitus more effectively. This is a must-attend event for audiologists looking to stay ahead in tinnitus care and improve patient outcomes. Hosted by Hearing Health & Technology Matters and Akoio?. ?? Register now - link in the comments.
-